Abcellera Biologics Inc share price logo

Abcellera Biologics Inc Share Price

NASDAQ: ABCL

Small Cap

$4.00

+0.17

(+4.57%)

as on

Abcellera Biologics Inc Stock Performance

as on April 18, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $3.87
    $4.05
    downward going graph

    3.25%

    Downside

    1.25%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.94
    $6.52
    downward going graph

    51.50%

    Downside

    62.87%

    Upside

    downward going graph

Abcellera Biologics Inc share price movements today

Previous Close
$3.83
Open
$3.93
Volume
6.2M
Day's Low - High
$3.87 - $4.05
52 Week Low - High
$1.94 - $6.52

Abcellera Biologics Inc Historical Returns

1 Month Return
+ 7.89 %
3 Month Return
-7.04 %
1 Year Return
+ 58.26 %
3 Year Return
-48.17 %
5 Year Return
-87.16 %

Abcellera Biologics Inc Stock Fundamentals & Key Indicators

Check Abcellera Biologics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.2B

EPS (TTM)

-0.7075

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.46%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-194.9M

Revenue (TTM)

75.1M

Profit Margin

-194.88%

Return On Equity TTM

-14.48%

Abcellera Biologics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Abcellera Biologics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Abcellera Biologics Inc image
Abcellera Biologics Inc
BUY$1.2B-87.16%NA-194.88%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$42.7B130.51%136.818.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.8B98.57%28.4232.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$36.8BNA129.845.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$78.9B48.43%17.9831.41%

Stock Returns calculator for Abcellera Biologics Inc Stock including INR - Dollar returns

The Abcellera Biologics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Abcellera Biologics Inc investment value today

Current value as on today

₹1,79,571

Returns

₹79,571

(+79.57%)

Returns from Abcellera Biologics Inc Stock

₹65,289 (+65.29%)

Dollar Impact

₹14,282 (+14.28%)

Analyst Recommendation on Abcellera Biologics Inc Stock

Based on 15 analysts

BUY

93.33%

Buy

6.67%

Hold

0.00%

Sell

Based on 15 analysts, 93.33% of analysts recommend a 'BUY' rating for Abcellera Biologics Inc. Average target price of $9.43

Abcellera Biologics Inc Share Price Target

Get share price movements and forecasts by analysts on Abcellera Biologics Inc.

What analysts predicted

57.58%UPSIDE

Target Price

$9.43

Current Price

$4

Analyzed by

15 Analysts

Target

$9.43

Abcellera Biologics Inc target price $9.43, a slight upside of 57.58% compared to current price of $4. According to 15 analysts rating.

Abcellera Biologics Inc Stock’s Investor Sentiment and Interest

Search interest for Abcellera Biologics Inc Stock has increased by 20% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:20% versus previous 30 day period

Abcellera Biologics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
6
9
9
7
6
5
4
17
8
44
Gross Profit
6
9
9
7
6
5
4
17
8
44
Operating Income
-54
-66
-54
-93
-93
-72
-62
-49
-76
-28
EBITDA
-44
-53
-44
-52
-51
-55
-51
-38
-66
-18
Interest Expense
-
16
-
-
-
-
8
-
-
16
Depreciation
7
9
6
38
38
13
6
7
7
7
Income Before Tax
-39
-48
-42
-48
-62
-46
-52
-36
-68
-19
Income Tax Expense
-10
-1
-2
-11
-11
-12
-7
-1
-11
-10
Net Income
-28
-47
-40
-36
-51
-34
-45
-34
-57
-8
Net Profit Margin
-433.55%
-513.67%
-407.98%
-504.30%
-785.42%
-677.43%
-1077.24%
-203.27%
-637.84%
-19.94%

Abcellera Biologics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
8
11
233
11
485
38
28
75
Gross Profit
8
11
206
11
418
38
28
75
Operating Income
0
-4
156
-4
216
-237
-314
-217
EBITDA
1
0
169
0
260
-192
-204
-155
Interest Expense
0
0
6
0
4
-
-
-
Depreciation
0
1
5
17
33
30
96
28
Income Before Tax
0
-2
157
-2
239
-174
-200
-177
Income Tax Expense
1
0
38
65
80
-27
-37
-31
Net Income
0
-2
118
-2
158
-146
-162
-146
Net Profit Margin
3.50%
-19.04%
51.00%
-19.04%
32.66%
-385.00%
-564.83%
-194.88%

Abcellera Biologics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-47
-40
-36
-51
-34
-45
-34
-57
-8
Operating Cash Flow
-19
-41
-29
-28
-8
-11
-32
-52
-34
Investing Cash Flow
-24
29
51
3
35
7
-31
36
75
Financing Cash Flow
3
2
2
3
4
5
-3
7
4
Change in Cash
-39
-9
24
-21
29
2
-66
-9
44

Abcellera Biologics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-2
118
153
158
-146
-162
-146
Operating Cash Flow
2
22
244
277
-43
-108
-131
Investing Cash Flow
-5
-119
-332
-352
-221
121
87
Financing Cash Flow
0
683
-3
-1
10
12
14
Change in Cash
-2
586
-92
-86
-254
23
-28

Global Institutional Holdings in Abcellera Biologics Inc

Funds
Holdings
Two Sigma Advisers, LLC
1.61%
The Goldman Sachs Group Inc
1.43%
Driehaus Capital Management LLC
1.24%
Morgan Stanley - Brokerage Accounts
0.92%
Lazard Asset Management LLC
0.22%
See all

Insights on Abcellera Biologics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 8.95M → 44.85M (in $), with an average increase of 80.0% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ABCL stock has moved up by 8.2%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -57.11M → -8.94M (in $), with an average increase of 538.6% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ABCL has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 21.1% return, outperforming this stock by 69.3%

About Abcellera Biologics Inc

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
OrganisationAbcellera Biologics Inc
Headquarters150 W 4th Avenue, Vancouver, BC, Canada, V5Y 1G6
IndustryBiotechnology
CEODr. Carl L.G. Hansen Ph.D.
E-voting on sharesClick here to vote

Key Management of Abcellera Biologics Inc

Name

Title

Mr. Tryn T. Stimart Esq., J.D., M.Sc.

Chief Legal Officer, Chief Compliance Officer, Corporate Secretary & Privacy Officer

Mr. Andrew Knowles M.Sc.

Vice President of Operations

Marcie Thiessen CPA, CGA

Senior Director of Finance & Accounting

Dr. Carl L.G. Hansen Ph.D.

CEO, President & Chairperson

Dr. Veronique Lecault Ph.D.

CTO & Director

Ms. Tiffany Chiu B.Sc., Ph.D.

Vice President of Communications

Caitlin Webster CIPD, M.Sc.

Director of Talent Development

Mr. Murray McCutcheon Ph.D.

Senior Vice President of Partnering

Mr. Andrew Booth M.B.A.

Chief Financial Officer

Mr. Martin Hogan M.Sc.

Senior Director of Strategic Finance & IR

FAQs

What is Abcellera Biologics Inc share price today?

Abcellera Biologics Inc share price today is $4 as on at the close of the market. Abcellera Biologics Inc share today touched a day high of $4.05 and a low of $3.87.

What is the 52 week high and 52 week low for Abcellera Biologics Inc share?

Abcellera Biologics Inc share touched a 52 week high of $6.52 on and a 52 week low of $1.94 on . Abcellera Biologics Inc stock price today i.e. is closed at $4,which is 38.60% down from its 52 week high and 106.19% up from its 52 week low.

What is Abcellera Biologics Inc's market capitalisation today?

Abcellera Biologics Inc market capitalisation is $0.00T as on .

How to invest in Abcellera Biologics Inc Stock (ABCL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Abcellera Biologics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Abcellera Biologics Inc Shares that will get you 0.3750 shares as per Abcellera Biologics Inc share price of $4 per share as on April 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Abcellera Biologics Inc Stock (ABCL) from India?

Indian investors can start investing in Abcellera Biologics Inc (ABCL) shares with as little as ₹92.768 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹927.68 in Abcellera Biologics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Abcellera Biologics Inc share’s latest price of $4 as on April 18, 2026 at 1:29 am IST, you will get 2.5000 shares of Abcellera Biologics Inc. Learn more about fractional shares .

What are the returns that Abcellera Biologics Inc has given to Indian investors in the last 5 years?

Abcellera Biologics Inc stock has given -87.16% share price returns and 24.45% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?